Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia.

about

KSHV Latency Locus Cooperates with Myc to Drive Lymphoma in Mice Mutation of NRAS but not KRAS significantly reduces myeloma sensitivity to single-agent bortezomib therapy.The Effect of Resveratrol on Cell Viability in the Burkitt's Lymphoma Cell Line Ramos.

P2860

Q28547671-0B04A593-71C1-41BA-934D-A4DBFE3DA959 Q41867768-5C68693D-236F-4F61-9E11-13801B8F35A9 Q48364974-A9108D0B-64AA-4124-BCA2-ADDD18C8ECEC

P2860

Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia.

Item

http://www.wikidata.org/entity/Q41121076

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Targeted overexpression of an ...... induce fatal B-cell neoplasia.

@en

type

Item

label

Targeted overexpression of an ...... induce fatal B-cell neoplasia.

@en

prefLabel

Targeted overexpression of an ...... induce fatal B-cell neoplasia.

@en

P1476

Targeted overexpression of an ...... induce fatal B-cell neoplasia.

@en

P2093

Brian G Van Ness

http://www.w3.org/2001/XMLSchema#string

Cathy S Carlson

http://www.w3.org/2001/XMLSchema#string

Michael A Linden

http://www.w3.org/2001/XMLSchema#string

Nicole Kirchhof

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical and biological significance of RAS mutations in multiple myeloma.

Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma

An unusual H-Ras mutant isolated from a human multiple myeloma line leads to transformation and factor-independent cell growth.

Combined Inactivation of MYC and K-Ras oncogenes reverses tumorigenesis in lung adenocarcinomas and lymphomas.

Rapid induction of IgM-secreting murine plasmacytomas by pristane and an immunoglobulin heavy-chain promoter/enhancer-driven c-myc/v-Ha-ras retrovirus.

A dominant-negative transgene defines a role for p56lck in thymopoiesis.

Novel targeted deregulation of c-Myc cooperates with Bcl-X(L) to cause plasma cell neoplasms in mice.

Selective synergy of immunoglobulin enhancer elements in B-cell development: a characteristic of kappa light chain enhancers, but not heavy chain enhancers

Molecular pathogenesis and a consequent classification of multiple myeloma.

Genetic events in the pathogenesis of multiple myeloma.

P304

216-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXPHEM.2011.11.006

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51836866

http://www.w3.org/2001/XMLSchema#string

P698

22120021

http://www.w3.org/2001/XMLSchema#string

P921

overexpression

P932

3279594

http://www.w3.org/2001/XMLSchema#string

Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia.

about

P2860

P2860

Targeted overexpression of an activated N-ras gene results in B-cell and plasma cell lymphoproliferation and cooperates with c-myc to induce fatal B-cell neoplasia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932